Ignatia Bryophyllum (Uriel Pharmacy Inc.)
Welcome to the PulseAid listing for the Ignatia Bryophyllum drug offered from Uriel Pharmacy Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Uriel Pharmacy Inc. |
NON-PROPRIETARY NAME: | Ignatia Bryophyllum |
SUBSTANCE NAME: | KALANCHOE DAIGREMONTIANA LEAF; STRYCHNOS IGNATII SEED; SILVER; LACHESIS MUTA VENOM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2009-09-01 |
END MARKETING DATE: | 0000-00-00 |
Ignatia Bryophyllum HUMAN OTC DRUG Details:
Item Description | Ignatia Bryophyllum from Uriel Pharmacy Inc. |
LABELER NAME: | Uriel Pharmacy Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 4; 10; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
START MARKETING DATE: | 2009-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 48951-5069_576e9282-5186-6536-e053-2a91aa0a6a4f |
PRODUCT NDC: | 48951-5069 |
APPLICATION NUMBER: | |
Other KALANCHOE DAIGREMONTIANA LEAF; STRYCHNOS IGNATII SEED; SILVER; LACHESIS MUTA VENOM Pharmaceutical Manufacturers / Labelers: